生物相容性
紫杉醇
纳米载体
PEG比率
药物输送
药理学
共轭体系
结合
化学
纳米技术
材料科学
癌症
医学
聚合物
有机化学
内科学
数学分析
经济
数学
财务
作者
Robyn M. Murphy,Min-Min Fan,Adbelbary Elhissi,Zhirong Zhang,Ka-Wai Wan,Waqar Ahmed,David A. Phoenix,Xan Sun
出处
期刊:Nanomedicine
[Future Medicine]
日期:2015-05-08
卷期号:10 (8): 1247-1262
被引量:53
摘要
Aim: The graphene oxide (GO) sheet has been considered one of the most promising carbon derivatives in the field of material science for the past few years and has shown excellent tumor-targeting ability, biocompatibility and low toxicity. We have endeavored to conjugate paclitaxel (PTX) to GO molecule and investigate its anticancer efficacy. Materials & Methods: We conjugated the anticancer drug PTX to aminated PEG chains on GO sheets through covalent bonds to get GO-PEG-PTX complexes. The tissue distribution and anticancer efficacy of GO-PEG-PTX were then investigated using a B16 melanoma cancer-bearing C57 mice model. Results: The GO-PEG-PTX complexes exhibited excellent water solubility and biocompatibility. Compared with the traditional formulation of PTX (Taxol®), GO-PEG-PTX has shown prolonged blood circulation time as well as high tumor-targeting and -suppressing efficacy. Conclusion: PEGylated graphene oxide is an excellent nanocarrier for paclitaxel for cancer targeting.
科研通智能强力驱动
Strongly Powered by AbleSci AI